- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
ProShares Ultra Nasdaq Biotechnology
+ Add to WatchlistBIB:US
99.0190 USD 0.9110 0.91%As of 20:10:00 ET on 05/24/2013.
Snapshot for ProShares Ultra Nasdaq Biotechnology (BIB)
| Open: | 98.6800 | High - Low: | 99.3400 - 96.7506 | Primary Exchange: | NASDAQ GM |
|---|---|---|---|---|---|
| Volume: | 38,824 | 52-Week Range: | 43.7550 - 107.0400 | Beta vs NBI: | 1.6576 |
Fund Profile & Information for BIB
ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index.
| Inception Date: | 2010-04-07 | Telephone: | 1-240-497-6400 |
|---|---|---|---|
| Managers: | HOWARD S RUBIN | ||
| Web Site: | www.proshares.com | ||
Fundamentals for BIB
| NAV | (on 2013-05-24) 99.0700 |
|---|---|
| Assets (M) | (on 2013-05-24) 113.9303 |
| Shares out (M) | 1.15 |
| Market Cap (M) | 113.87 |
| % Premium | -0.05 |
| Average 52-Week % Premium | 0.0018 |
| Fund Leveraged | Y |
| Fund Leverage Percent | 200.0000 % |
Dividends for BIB
| Dividend Type | Cancelled |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | - |
| Dividend Yield (ttm) | -% |
Performance for BIB
| 1-Month | +12.97% | 1-Year | +106.38% |
|---|---|---|---|
| 3-Month | +51.64% | 3-Year | +63.39% |
| Year To Date | +70.81% | 5-Year | - |
| Expense Ratio | 0.95 |
Top Fund Holdings for BIB
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 82,891 | 4,055,857 | 6.096% |
| Regeneron Pharmaceuticals Inc | 22,061 | 3,891,560 | 5.849% |
| Amgen Inc | 36,936 | 3,786,309 | 5.690% |
| Celgene Corp | 28,706 | 3,327,312 | 5.001% |
| Alexion Pharmaceuticals Inc | 32,004 | 2,948,849 | 4.432% |
| Biogen Idec Inc | 14,309 | 2,760,349 | 4.148% |
| Vertex Pharmaceuticals Inc | 32,631 | 1,794,052 | 2.696% |
| Perrigo Co | 14,453 | 1,716,005 | 2.579% |
| BioMarin Pharmaceutical Inc | 24,051 | 1,497,415 | 2.250% |
| Onyx Pharmaceuticals Inc | 15,541 | 1,380,973 | 2.075% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page